C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 5/062 (2006.01) A61K 31/195 (2006.01) A61K 31/52 (2006.01) A61K 38/05 (2006.01) C07C 237/22 (2006.01) C07K 14/035 (2006.01) A61K 38/00 (2006.01) A61K 7/00 (1995.01)
Patent
CA 2152541
Disclosed herein are compounds of the formula Image wherein R1 is hydrogen or (1-4C)alkyl, R2 is (1- 4C)alkyl or a therapeutically acceptable salt thereof. The compounds are useful for treating herpes infections.
La divulgation concerne des composés de formule Image - où R1 est de l'hydrogène ou un alkyle (1-4C) et R2 un alkyle (1- 4C) -, ou un sel de ces composés, de qualité thérapeutique. Ces composés sont utiles pour traiter les infections de type herpétiques.
Gauthier Jean Andre
Moss Neil
Boehringer Ingelheim (canada) Ltd. Boehringer Ingelheim (canada)
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Herpes ribonucleotide reductase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpes ribonucleotide reductase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes ribonucleotide reductase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1508044